LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Pelitinib	3.33	uM	LJP5	72	hr	1657	4353	5588	0.7790	0.7341
BT-20	Pelitinib	10	uM	LJP5	72	hr	1657	1202	5588	0.2152	-0.1674
BT-20	Luminespib	0.04	uM	LJP5	72	hr	1657	1802	5588	0.3225	0.0487
BT-20	Luminespib	0.12	uM	LJP5	72	hr	1657	1796	5588	0.3215	0.0469
BT-20	Luminespib	0.37	uM	LJP5	72	hr	1657	1790	5588	0.3205	0.0450
BT-20	Luminespib	1.11	uM	LJP5	72	hr	1657	1762	5588	0.3155	0.0357
BT-20	Luminespib	3.33	uM	LJP5	72	hr	1657	1774	5588	0.3175	0.0394
BT-20	Luminespib	10	uM	LJP5	72	hr	1657	1806	5588	0.3233	0.0502
BT-20	AZD8330	0.04	uM	LJP5	72	hr	1657	4063	5588	0.7273	0.6677
BT-20	AZD8330	0.12	uM	LJP5	72	hr	1657	4338	5588	0.7765	0.7313
BT-20	AZD8330	0.37	uM	LJP5	72	hr	1657	4424	5588	0.7918	0.7506
BT-20	AZD8330	1.11	uM	LJP5	72	hr	1657	4371	5588	0.7823	0.7385
BT-20	AZD8330	3.33	uM	LJP5	72	hr	1657	4563	5588	0.8167	0.7817
BT-20	AZD8330	10	uM	LJP5	72	hr	1657	4562	5588	0.8165	0.7816
BT-20	TGX221	0.04	uM	LJP5	72	hr	1657	5249	5588	0.9394	0.9294
BT-20	TGX221	0.12	uM	LJP5	72	hr	1657	5209	5588	0.9326	0.9213
BT-20	TGX221	0.37	uM	LJP5	72	hr	1657	5559	5588	0.9949	0.9942
BT-20	TGX221	1.11	uM	LJP5	72	hr	1657	5449	5588	0.9751	0.9714
BT-20	TGX221	3.33	uM	LJP5	72	hr	1657	5556	5588	0.9942	0.9933
BT-20	TGX221	10	uM	LJP5	72	hr	1657	5980	5588	1.0703	1.0790
BT-20	GSK1059615	0.04	uM	LJP5	72	hr	1657	5546	5588	0.9929	0.9914
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1657	4714	5383	0.8758	0.8499
BT-20	GSK1059615	0.12	uM	LJP5	72	hr	1657	4269	5588	0.7641	0.7153
BT-20	GSK1059615	0.12	uM	LJP6	72	hr	1657	2789	5383	0.5184	0.3585
BT-20	GSK1059615	0.37	uM	LJP5	72	hr	1657	1994	5588	0.3571	0.1105

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)